TGFBR1∗6A and cancer: A meta-analysis of 12 case-control studies

Journal of Clinical Oncology

Volumn 22, Issue 4, 2004, Pages 756-758

  Pasche, Boris ^a   Kaklamani, Virginia ^a   Hou, Nanjiang ^a   Young, Taya ^a   Rademaker, Alfred ^a   Peterlongo, Paolo ^b   Ellis, Nathan ^b   Offit, Kenneth ^b   Caldes, Trinidad ^c   Reiss, Michael ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR 1; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

CLINICAL TRIAL; EPIDEMIOLOGY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HUMAN; LETTER; META ANALYSIS; NEOPLASM;

ACTIVIN RECEPTORS, TYPE I; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 1442356678     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2004.99.271     Document Type: Letter

References (1)

1. Kaklamani V, Hou N, Bian Y, et al: TGFBR1∗6A and cancer risk: A metaanalysis of seven case-control studies. J Clin Oncol 21:3236-3243, 2003